The effectiveness of 2-PAM and of EA 1814 as adjuncts to atropine therapy in dogs exposed to GB vapor by inhalation.
D000818:Animals; D001285:Atropine; D002800:Cholinesterase Inhibitors; D004285:Dogs; D005740:Gases; D010710:Phosphates / Q000633:toxicity*; D011220:Pralidoxime Compounds; D011725:Pyridines / Q000494:pharmacology*
D002800:Cholinesterase Inhibitors; D005740:Gases; D010710:Phosphates; D011220:Pralidoxime Compounds; D011725:Pyridines; D001285:Atropine; C028797:pralidoxime
CHOLINESTERASE/antagonists; PHOSPHATES/toxicology; PYRIDINES/pharmacology